«

»

Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery

The Utah-based biotech company’s agreement with Bayer is potentially worth over $1 billion.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive